- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01544868
Total Energy Expenditure, Protein Kinetics, and Body Composition in Recovering Burn Children. (TEE)
Total Energy Expenditure, Protein Kinetics and Body Composition During Recovery From Severe Burn Injury in Children.
Study Overview
Status
Intervention / Treatment
Detailed Description
Measures of total and resting energy expenditure, protein turnover, body composition and other nutritional and outcome-based measures will be made in patients receiving inpatient rehabilitative care for their burn injury. Patients will consist of acutely burned patients initially admitted to our hospital with burns of 40% of their total body, who have recently recovered from their acute phase of injury and have achieved wound closure as defined by less than 5% open wound area (Group A). In addition, patients admitted to the hospital for "acute rehabilitation", which includes patients in need of rehabilitative therapy will also be included. This latter group (Group B) is unique in that the patients may have open wound areas remaining due to difficulty healing, however are not critically ill. Group B may differ from the typical rehabilitation population seen at our hospital because of their open wounds and because they received care for their initial injury elsewhere. They are included here due to their apparent nutritional compromise and their unique energy and protein requirements that are difficult to predict according to our clinical experience. These patients are most likely to require artificial nutrition support and will benefit from information gained by this study.
Measurements will be made at baseline as defined at the time of wound closure (or at the time of admission for Group B). Subsequent measures will be done as follows: 1) total energy expenditure will be assessed weeks 1-3 and again at weeks 7-9. During weeks 1 and 7, protein turnover studies will take place. Indirect calorimetry and physical activity measures will take place on 2 consecutive days during each week. Lean body mass measurements will be done at the time of wound closure and at discharge. The study will end at the time of discharge.
Resting and total energy expenditure will be done using indirect calorimetry for resting energy expenditure and the doubly labeled water method for total energy expenditure. Briefly, the methodology for doubly labeled water is as follows. Two pre-dose urine specimens will be collected prior to an oral dose containing 0.22 g/kg total body water of 100% 18O water (or 1.2 g/kg per body weight of 10% 18O water) and 0.11 g/kg per body weight of 99.9% deuterium oxide. Three post-dose urine voids will be collected, followed by collection of a morning urine void daily for 7 days. Total energy expenditure by this method will represent the average energy expenditure over a 21-day period. It will be obtained at weeks 1-3 and again at weeks 7-9 weeks during the rehabilitative phase. Resting energy expenditure will be determined using indirect calorimetry by a metabolic cart on 2 consecutive days of each week. Physical activity will be determined by having the patients wear an physical activity monitor (Actical Physical Monitoring System, mini-Mitter, Co., Inc, Bend Oregon) on their wrist, ankle or hand for the entire day twice a week (corresponding to the metabolic cart measurement). This will be worn on 2 days of each week. Protein nutritional status and turnover will be measured using N15 glycine. Three methyl-histidine will be measured at the time of N15 glycine studies (weeks 1 and 7) to assess the contribution of muscle mass to protein turnover. On the day of tracer study, each patient will provide a urine sample, and this urine sample will be collected to determine the basal level of N15 enrichment in urea and ammonia. Then the patient will receive a single dose (4mg/kg, less than 2% of normal daily intake of 1.1g per person) of 15N glycine tracer. For this, patients will drink a dose of 15N glycine (4mg.kg 1dissolved in 20 ml of saline) mixed in 50 cc of apple juice or other liquid beverage, followed by a 50 cc wash of water. 24 hour urine collection will commence immediately. Twenty-four hour urines will be used for determining the 15N NH3 and 15N urea enrichment. Each urine container will contain 5 ml of 15N HCl for trapping the urinary ammonium. Urine will be collected each day for 3 days, for determination of the total urinary nitrogen, urea creatinine, and ammonia excretion.
Lean body mass, fat mass and bone mineral density and content will be determined at baseline (or at the time of wound closure- as is routine care) and at discharge. Body composition components (lean body mass, fat mass and bone mineral density) will be determined for the lumbar spine and the whole body using dual energy x-ray absorptiometry (DXA) with a Discovery QDR 4500 A (Hologic, Waltham, MA) in burned and healthy children. Scanning will be performed by study staff trained and certified in the use of DXA. DXA uses x-ray beams at two photon energies to estimate body composition. Prior to the scan, height will be measured at the time of each measurement session with the subjects standing barefoot and in light clothing using a stadiometer. Measures will be recorded to the nearest 0.5 centimeters respectively. Weight will be taken using a balance scale and recorded to the nearest 0.5 kilograms. DXA measurements will be done by having the patient lie flat on his or her back on the DXA scanning table. Subjects will be positioned by the scanner so that the spine is straight on the table pad. For the lumbar spine measurement, a knee positioner will be placed under the patient's lower legs so that the patient's knees and hip are at a 90 degree angle. To align the C-arm (scanning arm ) of the DXA, a laser line will be positioned 1-2 inches below the patient's ileac crest, centered around the patient's midline. The scan time approximates 10 seconds, exposure is 0.38 mRem. For the whole body scan, the subject will lay on his or her back with their body straight, arms at sides, palms down, separated from thighs. The scanner will rotate the subject's legs inward 25 degrees until the toes touch, using tape around the feet to maintain this position. The subject will be instructed to breathe normally. The total scan time approximates 2.5 to 3.5 minutes with an exposure of 0.26 mRem. Total body fat and lean body mass will be determined by the DEXA as described as part of the whole body bone mineral density scan (only 1 scan session required). Measures of % body fat content and % lean body mass content for the whole body will be obtained using the DEXA software. These values will be compared to age and sex matched pediatric reference data for body composition {{217 Ellis, K.J. 2000; }}.
Because measures of LBM can be confounded by hydration status, a second measure of LBM using bioelectrical impedance will be made at these points and compared.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02446
- Shriners Hospitals For Chidren
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients > 2 less than 18 who have been admitted to our hospital for treatment of an initial wound size of 40% or greater total body surface area burn, which has subsequently healed
Exclusion Criteria:
- hemodynamically unstable
- not receiving enteral nutrition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Energy expenditure measurement
Descriptive measurements
|
Two pre-dose urine specimens will be collected prior to an oral dose containing 0.22 g/kg total body water of 100% 18O water (or 1.2 g/kg per body weight of 10% 18O water) and 0.11 g/kg per body weight of 99.9% deuterium oxide.
Then the patient will receive a single dose (4mg/kg, less than 2% of normal daily intake of 1.1g per person) of 15N glycine tracer.
For this, patients will drink a dose of 15N glycine (4mg.kg
1dissolved in 20 ml of saline) mixed in 50 cc of apple juice or other liquid beverage, followed by a 50 cc wash of water.
24 hour urine collection will commence immediately.
Twenty-four hour urines will be used for determining the 15N NH3 and 15N urea enrichment.
Each urine container will contain 5 ml of 15N HCl for trapping the urinary ammonium.
Urine will be collected each day for 3 days, for determination of the total urinary nitrogen, urea creatinine, and ammonia excretion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Energy Expenditure
Time Frame: 4 years
|
Tota Energy Expenditure will be determined in this group of burn children
|
4 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Protein Turnover
Time Frame: 4 years
|
Protein synthesis and breakdown will determined by stable isotope methodology
|
4 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2006P001559
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Energy Expenditure in Burn Children
-
Mahidol UniversityInternational Atomic Energy Agency; Food and Nutrition Research Institute,... and other collaboratorsActive, not recruitingBody Composition | Energy Expenditure | Infant and Young Child Feeding | Infants and Young ChildrenThailand
-
Hospices Civils de LyonCompleted
-
University of South CarolinaCompleted
-
Catholic University of BrasíliaCompletedEnergy Expenditure
-
Clinical Nutrition Research Centre, SingaporeCompletedEnergy ExpenditureSingapore
-
Pennington Biomedical Research CenterCompletedEnergy ExpenditureUnited States
-
American University of Beirut Medical CenterUnknownEnergy ExpenditureLebanon
-
Institut National de Recherche pour l'Agriculture...Centre de Recherche en Nutrition Humaine Rhone-Alpe; Centre de Recherche en...CompletedEnergy Expenditure | Computer Simulation | Energy MetabolismFrance
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling by invitation
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
Clinical Trials on Use of Stable Isotope to Measure Energy Expenditure and Protein Turnover
-
University of EdinburghRoyal College of Surgeons of EdinburghCompletedLiver ResectionUnited Kingdom
-
International Atomic Energy AgencyCentre National De L'énergie, Des Sciences Et Techniques Nucléaires; Institut... and other collaboratorsCompletedNutritional Deficiency | Nutritional Stunting | Protein MalabsorptionMorocco
-
University of Texas Southwestern Medical CenterDana S HardinWithdrawn
-
Society for Applied StudiesWorld Health Organization; Christian Medical College, Vellore, India; ArthCompletedUncomplicated Severe Acute MalnutritionIndia
-
University of California, BerkeleyUnited States Agency for International Development (USAID); Impact Carbon,... and other collaboratorsCompletedBehavior | Air Pollution, IndoorUnited States, Uganda
-
University of Texas Southwestern Medical CenterGenentech, Inc.Withdrawn
-
International Centre for Diarrhoeal Disease Research...Washington University School of MedicineRecruiting
-
Vital Pakistan TrustAga Khan UniversityActive, not recruiting
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Not yet recruitingAdvanced or Metastatic NSCLCChina
-
PfizerCompletedCarcinoma, Renal CellUnited States, Canada, Spain, Australia, Germany, Italy, Russian Federation, Brazil, France, United Kingdom, Poland